Abstract

The incidence of Alzheimer’s Disease in females is almost double that of males. To search for sex-specific gene associations, we build a machine learning approach focused on functionally impactful coding variants. This method can detect differences between sequenced cases and controls in small cohorts. In the Alzheimer’s Disease Sequencing Project with mixed sexes, this approach identified genes enriched for immune response pathways. After sex-separation, genes become specifically enriched for stress-response pathways in male and cell-cycle pathways in female. These genes improve disease risk prediction in silico and modulate Drosophila neurodegeneration in vivo. Thus, a general approach for machine learning on functionally impactful variants can uncover sex-specific candidates towards diagnostic biomarkers and therapeutic targets.

More females than males suffer from Alzheimer’s Disease for reasons not well understood. Here, using a novel machine learning approach focused on functionally impactful coding variants, the authors identify potential sex-specific modulators of neurodegeneration.

Details

Title
Functional variants identify sex-specific genes and pathways in Alzheimer’s Disease
Author
Bourquard, Thomas 1 ; Lee, Kwanghyuk 1   VIAFID ORCID Logo  ; Al-Ramahi, Ismael 2 ; Pham, Minh 1 ; Shapiro, Dillon 1   VIAFID ORCID Logo  ; Lagisetty, Yashwanth 3 ; Soleimani, Shirin 1 ; Mota, Samantha 1 ; Wilhelm, Kevin 1   VIAFID ORCID Logo  ; Samieinasab, Maryam 1 ; Kim, Young Won 1 ; Huh, Eunna 1 ; Asmussen, Jennifer 1 ; Katsonis, Panagiotis 1   VIAFID ORCID Logo  ; Botas, Juan 2   VIAFID ORCID Logo  ; Lichtarge, Olivier 4   VIAFID ORCID Logo 

 Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X) 
 Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X); Texas Children’s Hospital, Jan and Dan Duncan Neurological Research Institute, Houston, USA (GRID:grid.416975.8) (ISNI:0000 0001 2200 2638); Baylor College of Medicine, Center for Alzheimer’s and Neurodegenerative Diseases, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X) 
 Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X); UTHealth McGovern Medical School, Department of Biology and Pharmacology, Houston, USA (GRID:grid.39382.33) 
 Baylor College of Medicine, Department of Molecular and Human Genetics, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X); Baylor College of Medicine, Center for Alzheimer’s and Neurodegenerative Diseases, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X); Baylor College of Medicine, Computational and Integrative Biomedical Research Center, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X) 
Pages
2765
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2813082862
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.